1. Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients. Issue 1 (December 2015) Authors: Smolen, Josef; van Vollenhoven, Ronald; Kavanaugh, Arthur; Strand, Vibeke; Vencovsky, Jiri; Schiff, Michael; Landewé, Robert; Haraoui, Boulos; Arendt, Catherine; Mountian, Irina; Carter, David; van der Heijde, Désirée Journal: Arthritis research & therapy Issue: Volume 17:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗